Statistics about Health, Pharma & Medtech in United States
Statistics
- Integrated Biopharma Inc liabilities 2020-2024
- Q Biomed gross profit 2020-2022
- In8Bio net cash 2020-2023
- Integrated Biopharma Inc net cash 2020-2024
- Igm Biosciences total assets 2019-2023
- Glucose Health total equity 2012-2016
- Genelux revenue 2022-2023
- Gelesis Holdings total equity 2019-2022
- Gelesis Holdings total assets 2020-2022
- Genelux operating profit 2022-2023
- Sibannac operating profit 2015-2016
- Gelesis Holdings liabilities 2020-2022
- Ideaya Biosciences total assets 2019-2023
- Poseida Therapeutics operating profit 2019-2023
- Intensity Therapeutics net cash 2022-2023
- Glucose Health liabilities 2012-2016
- Insmed net cash 2019-2023
- Gelesis Holdings revenue 2021-2022
- Glucose Health total assets 2012-2016
- Immunic net cash 2019-2023
- Infinity Pharmaceuticals net cash 2018-2022
- Gelesis Holdings net income 2020-2022
- Gelesis Holdings operating profit 2020-2022
- Protagonist Therapeutics operating profit 2019-2023
- Glucose Health net cash 2012-2016
- Sibannac liabilities 2012-2016
- Gossamer Bio operating profit 2019-2023
- Immunitybio revenue 2019-2023
- Ironwood Pharmaceuticals total equity 2019-2023
- Gain Therapeutics total equity 2019-2023
- Gain Therapeutics net cash 2020-2023
- Gain Therapeutics total assets 2020-2023
- Sensei Biotherapeutics total assets 2020-2023
- Gain Therapeutics operating profit 2020-2023
- Iveric Bio, Inc. total equity 2018-2022
- Gain Therapeutics liabilities 2020-2023
- Gain Therapeutics revenue 2020-2023
- Sibannac total assets 2012-2016
- Skye Bioscience total equity 2019-2023
- Gain Therapeutics net income 2020-2023
- Iovance Biotherapeutics, Inc. total equity 2019-2023
- Ionis Pharmaceuticals total equity 2019-2023
- Iveric Bio, Inc. total assets 2018-2022
- Ironwood Pharmaceuticals total assets 2019-2023
- Gyre Therapeutics, Inc. net cash 2019-2023
- Gyre Therapeutics, Inc. total assets 2019-2023
- Gyre Therapeutics, Inc. total equity 2019-2023
- Gyre Therapeutics, Inc. liabilities 2019-2023
- Senti Biosciences total assets 2021-2023
- Greenlight Biosciences Holdings, Pbc net income 2021-2022
- Ionis Pharmaceuticals total assets 2019-2023
- Invivyd total equity 2020-2023
- Immunitybio net income 2019-2023
- Sibannac total equity 2012-2016
- Imunon total equity 2019-2023
- Imunon total assets 2019-2023
- Imunon operating profit 2019-2023
- Imunon liabilities 2019-2023
- Imunon net cash 2019-2023
- Imunon revenue 2018-2022
- Invivyd liabilities 2020-2023
- Greenlight Biosciences Holdings, Pbc revenue 2021-2022
- Invivyd total assets 2020-2023
- Invivyd net income 2021-2023
- Invivyd net cash 2021-2023
- Invivyd operating profit 2021-2023
- Greenlight Biosciences Holdings, Pbc total assets 2020-2022
- Greenlight Biosciences Holdings, Pbc total equity 2020-2022
- Greenlight Biosciences Holdings, Pbc operating profit 2021-2022
- Greenlight Biosciences Holdings, Pbc liabilities 2020-2022
- Greenlight Biosciences Holdings, Pbc net cash 2021-2022
- Gyre Therapeutics, Inc. net income 2019-2023
- Gyre Therapeutics, Inc. operating profit 2019-2023
- Gossamer Bio total equity 2019-2023
- Guardion Health Sciences total equity 2019-2023
- Geovax Labs, Inc. revenue 2019-2023
- Geovax Labs, Inc. operating profit 2019-2023
- Ironwood Pharmaceuticals operating profit 2019-2023
- Iovance Biotherapeutics, Inc. operating profit 2019-2023
- Guardion Health Sciences total assets 2019-2023
- Ionis Pharmaceuticals operating profit 2019-2023
- Guardion Health Sciences liabilities 2019-2023
- Guardion Health Sciences operating profit 2019-2023
- Guardion Health Sciences net cash 2019-2023
- Geovax Labs, Inc. total assets 2019-2023
- Guardion Health Sciences gross profit 2019-2023
- Guardion Health Sciences revenue 2019-2023
- Ironwood Pharmaceuticals revenue 2019-2023
- Iveric Bio, Inc. revenue 2016-2019
- Sensei Biotherapeutics liabilities 2020-2023
- Ionis Pharmaceuticals revenue 2019-2023
- Senti Biosciences liabilities 2021-2023
- Skye Bioscience net cash 2019-2023
- Gossamer Bio net cash 2019-2023
- Iveric Bio, Inc. operating profit 2018-2022
- Geovax Labs, Inc. total equity 2019-2023
- Gyre Therapeutics, Inc. revenue 2018-2023
- Greenwich Lifesciences operating profit 2019-2023
- Iovance Biotherapeutics, Inc. total assets 2019-2023
- Ironwood Pharmaceuticals net cash 2019-2023